Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
5 Years
2.2
-285.30%
Never
—
50.25%
80%
—
5 Years
Score2.2
Net Growth-285.30%
Net TrendNever
Net Income Consistency—
Rev Growth50.25%
Rev Trend80%
Revenue Consistency—
Cytokinetics Inc fundamental performance
Between 2020 and 2025, revenue grew from $ 55M to $ 88M and net income went from -$ 127M to -$ 784M. Revenue increased in 4 of those 5 years; net income in 0.
Between 2005 and 2025, revenue grew from $ 8M to $ 88M and net income went from -$ 42M to -$ 784M. Revenue increased in 14 of those 20 years; net income in 8.
Cytokinetics Inc currently holds a 20-year HDB Score of 2.8 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 75.64 | — |
1 Year2025-08-12 | $ 34.31 | 120.46% |
5 Years2021-08-12 | $ 32.43 | 133.24% |
10 Years2016-08-12 | $ 12.15 | 6x |
20 Years2006-08-11 | $ 34.50 | 119.25% |
All Time2004-04-29 | $ 16.10 | 369.81% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | 10 Years2016-08-12 | 20 Years2006-08-11 | All Time2004-04-29 |
|---|---|---|---|---|---|---|
| Price | $ 75.64 | $ 34.31 | $ 32.43 | $ 12.15 | $ 34.50 | $ 16.10 |
| Return | — | 120.46% | 133.24% | 6x | 119.25% | 369.81% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 105M | -$ 829M | $ 818M |
| 2025 | $ 88M | -$ 784M | $ 882M |
| 2024 | $ 18M | -$ 589M | $ 1.07B |
| 2023 | $ 7M | -$ 526M | $ 614M |
| 2022 | $ 94M | -$ 388M | $ 782M |
| 2021 | $ 70M | -$ 215M | $ 471M |
| 2020 | $ 55M | -$ 127M | $ 464M |
| 2019 | $ 26M | -$ 121M | $ 225M |
| 2018 | $ 31M | -$ 106M | $ 198M |
| 2017 | $ 13M | -$ 127M | $ 268M |
| 2016 | $ 106M | $ 16M | $ 156M |
| 2015 | $ 28M | -$ 37M | $ 111M |
| 2014 | $ 46M | -$ 14M | $ 83M |
| 2013 | $ 30M | -$ 33M | $ 77M |
| 2012 | $ 7M | -$ 41M | $ 74M |
| 2011 | $ 4M | -$ 47M | $ 49M |
| 2010 | $ 2M | -$ 49M | $ 71M |
| 2009 | $ 81M | $ 24M | $ 114M |
| 2008 | $ 12M | -$ 56M | $ 56M |
| 2007 | $ 13M | -$ 48M | $ 119M |
| 2006 | $ 3M | -$ 57M | $ 109M |
| 2005 | $ 8M | -$ 42M | $ 76M |
| IPO2004 | $ 13M | -$ 37M | $ 105M |
Explore beyond CYTK
You're looking at Cytokinetics Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
